Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

Background: Although catalytic properties of different genetic polymorphisms of VKORC1 and CYP2C9 products have been identified, there is limited study available regarding warfarin dose requirement in Iranian patient population. This study investigates the impact of these polymorphisms on 115 patien...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Hematol Oncol Stem Cell Res
Päätekijät: Poopak, Behzad, Rabieipoor, Saghar, Safari, Nazila, Naraghi, Emadedin, Sheikhsofla, Fatemeh, Khosravipoor, Gelareh
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748690/
https://ncbi.nlm.nih.gov/pubmed/26865929
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia